Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
18 Oct 2024
Historique:
received: 15 02 2024
accepted: 10 10 2024
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: epublish

Résumé

Infections with Enterobacterales (E) are increasingly difficult to treat due to antimicrobial resistance. After ceftriaxone replaced chloramphenicol (CHL) as empiric therapy for suspected sepsis in Malawi in 2004, extended-spectrum beta-lactamase (ESBL)-E rapidly emerged. Concurrently, resistance to CHL in Escherichia coli and Klebsiella spp. decreased, raising the possibility of CHL re-introduction. However, many phenotypically susceptible isolates still carry CHL acetyltransferase (cat) genes. To understand the molecular mechanisms and stability of this re-emerging CHL susceptibility we use a combination of genomics, phenotypic susceptibility assays, experimental evolution, and functional assays for CAT activity. Here, we show that of 840 Malawian E. coli and Klebsiella spp. isolates, 31% have discordant CHL susceptibility genotype-phenotype, and we select a subset of 42 isolates for in-depth analysis. Stable degradation of cat genes by insertion sequences leads to re-emergence of CHL susceptibility. Our study suggests that CHL could be reintroduced as a reserve agent for critically ill patients with ESBL-E infections in Malawi and similar settings and highlights the ongoing challenges in inferring antimicrobial resistance from sequence data.

Identifiants

pubmed: 39424629
doi: 10.1038/s41467-024-53391-2
pii: 10.1038/s41467-024-53391-2
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6
Anti-Bacterial Agents 0
Chloramphenicol 66974FR9Q1
Chloramphenicol O-Acetyltransferase EC 2.3.1.28

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9019

Subventions

Organisme : Unilever
ID : MA-2021-00523N
Organisme : Unilever
ID : MA-2021-00523N
Organisme : Unilever
ID : MA-2021-00523N
Organisme : Unilever
ID : MA-2021-00523N
Organisme : Unilever
ID : MA-2021-00523N
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/N013514/1
Organisme : Research Councils UK (RCUK)
ID : MR/W030578/1
Organisme : Research Councils UK (RCUK)
ID : 107136
Organisme : Research Councils UK (RCUK)
ID : 107136
Organisme : Research Councils UK (RCUK)
ID : 107136
Organisme : Research Councils UK (RCUK)
ID : MR/W030578/1
Organisme : Research Councils UK (RCUK)
ID : 107136
Organisme : Research Councils UK (RCUK)
ID : 107136

Informations de copyright

© 2024. The Author(s).

Références

Antimicrobial Resistance C. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
doi: 10.1016/S0140-6736(21)02724-0
Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318–327 (2018).
pubmed: 29276051 doi: 10.1016/S1473-3099(17)30753-3
Lester, R. et al. Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study. Lancet Microbe 3, e922–e930 (2022).
pubmed: 36335953 pmcid: 9712123 doi: 10.1016/S2666-5247(22)00282-8
Lester, R. et al. Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi. PLOS Glob. Public Health 3, e0001589 (2023).
pubmed: 37347746 pmcid: 10287011 doi: 10.1371/journal.pgph.0001589
Musicha, P. et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect. Dis. 17, 1042–1052 (2017).
pubmed: 28818544 pmcid: 5610140 doi: 10.1016/S1473-3099(17)30394-8
Ministry of Health GoM. Malawi Standard Treatment Guidelines (MSTG) 5th edn (The Secretary of Health, Malwai) (2015).
Ehrlich, J., Bartz, Q. R., Smith, R. M., Joslyn, D. A. & Burkholder, P. R. Chloromycetin, a new antibiotic from a soil actinomycete. Science 106, 417 (1947).
pubmed: 17737966 doi: 10.1126/science.106.2757.417
Eliakim-Raz, N. et al. Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 70, 979–996 (2015).
pubmed: 25583746 doi: 10.1093/jac/dku530
Rheingold, J. J. & Spurling, C. L. Chloramphenicol and aplastic anemia. J. Am. Med Assoc. 119, 1301–1304 (1952).
pubmed: 14938166 doi: 10.1001/jama.1952.02930310037008
Schilling, C. G., Larson, T. A. & Uden, D. L. Chloramphenicol-associated aplastic anemia. J. Pharm. Technol. 4, 54–59 (1988).
doi: 10.1177/875512258800400206
Martelo, O. J., Manyan, D. R., Smith, U. S. & Yunis, A. A. Chloramphenicol and bone marrow mitochondria. J. Lab Clin. Med 74, 927–940 (1969).
pubmed: 5359665
McIntyre, J. & Choonara, I. Drug toxicity in the neonate. Biol. Neonate 86, 218–221 (2004).
pubmed: 15249753 doi: 10.1159/000079656
Schwarz, S., Kehrenberg, C., Doublet, B. & Cloeckaert, A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 28, 519–542 (2004).
pubmed: 15539072 doi: 10.1016/j.femsre.2004.04.001
Lewis, J. M. et al. Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults. Nat. Microbiol. 7, 1593–1604 (2022).
pubmed: 36065064 pmcid: 9519460 doi: 10.1038/s41564-022-01216-7
Musicha, P. et al. Genomic landscape of extended-spectrum beta-lactamase resistance in Escherichia coli from an urban African setting. J. Antimicrob. Chemother. 72, 1602–1609 (2017).
pubmed: 28333330 pmcid: 5437524 doi: 10.1093/jac/dkx058
Musicha, P. et al. Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages. J. Antimicrob. Chemother. 74, 1223–1232 (2019).
pubmed: 30778540 pmcid: 6477993 doi: 10.1093/jac/dkz032
Lewis, J. M. et al. Genomic and antigenic diversity of colonizing Klebsiella pneumoniae isolates mirrors that of invasive isolates in Blantyre, Malawi. Microb. Genom. 8, 000778 (2022).
Lewis, J. M. et al. Genomic analysis of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli colonising adults in Blantyre, Malawi reveals previously undescribed diversity. Microb. Genom. 9, mgen001035 (2023).
Azemun, P., Stull, T., Roberts, M. & Smith, A. L. Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 20, 168–170 (1981).
pubmed: 6974540 pmcid: 181658 doi: 10.1128/AAC.20.2.168
Slack, M. P., Wheldon, D. B. & Turk, D. C. Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Lancet 2, 1366 (1977).
pubmed: 74780 doi: 10.1016/S0140-6736(77)90426-3
Projan, S. J. et al. Comparative sequence and functional analysis of pT181 and pC221, cognate plasmid replicons from Staphylococcus aureus. Mol. Gen. Genet 199, 452–464 (1985).
pubmed: 2993795 doi: 10.1007/BF00330758
Lovett, P. S. Translational attenuation as the regulator of inducible cat genes. J. Bacteriol. 172, 1–6 (1990).
pubmed: 2403536 pmcid: 208393 doi: 10.1128/jb.172.1.1-6.1990
Balleza, E., Kim, J. M. & Cluzel, P. Systematic characterization of maturation time of fluorescent proteins in living cells. Nat. Methods 15, 47–51 (2018).
pubmed: 29320486 doi: 10.1038/nmeth.4509
Lewis J. M. Causes and Consequences of Adult Sepsis in Blantyre (Malawi, 2019).
Partridge, S. R., Zong, Z. & Iredell, J. R. Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli. Antimicrob. Agents Chemother. 55, 4971–4978 (2011).
pubmed: 21859935 pmcid: 3195058 doi: 10.1128/AAC.00025-11
Pong, C. H., Moran, R. A. & Hall, R. M. Evolution of IS26-bounded pseudo-compound transposons carrying the tet(C) tetracycline resistance determinant. Plasmid 112, 102541 (2020).
pubmed: 32979461 doi: 10.1016/j.plasmid.2020.102541
Woodford, N. et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 53, 4472–4482 (2009).
pubmed: 19687243 pmcid: 2764225 doi: 10.1128/AAC.00688-09
Inouye, M. et al. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med. 6, 90 (2014).
pubmed: 25422674 pmcid: 4237778 doi: 10.1186/s13073-014-0090-6
McArthur, A. G. et al. The comprehensive antibiotic resistance database. Antimicrob. Agents Chemother. 57, 3348–3357 (2013).
pubmed: 23650175 pmcid: 3697360 doi: 10.1128/AAC.00419-13
Florensa A. F., Kaas R. S., Clausen P., Aytan-Aktug D., & Aarestrup F. M. ResFinder—an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes. Microb. Genom. 8, 000748 (2022).
Quiroga, M. P. et al. Complex class 1 integrons with diverse variable regions, including aac(6’)-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob. Agents Chemother. 51, 4466–4470 (2007).
pubmed: 17938184 pmcid: 2167984 doi: 10.1128/AAC.00726-07
Nielsen T. K., Browne P. D., & Hansen L. H. Antibiotic resistance genes are differentially mobilized according to resistance mechanism. Gigascience 11, giac072 (2022).
Williams, C. T., Musicha, P., Feasey, N. A., Adams, E. R. & Edwards, T. ChloS-HRM, a novel assay to identify chloramphenicol-susceptible Escherichia coli and Klebsiella pneumoniae in Malawi. J. Antimicrob. Chemother. 74, 1212–1217 (2019).
pubmed: 30689880 pmcid: 6477986 doi: 10.1093/jac/dky563
Veech, J. A. & Peres-Neto, P. A probabilistic model for analysing species co-occurrence. Glob. Ecol. Biogeogr. 22, 252–260 (2013).
doi: 10.1111/j.1466-8238.2012.00789.x
Feldgarden, M. et al Curation of the AMRFinderPlus databases: applications, functionality and impact. Microb. Genom. 8, mgen000832 (2022).
Phan, M. D. et al. Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131. Antimicrob. Agents Chemother. 66, e0214621 (2022).
pubmed: 34780264 doi: 10.1128/AAC.02146-21
Petty, N. K. et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc. Natl. Acad. Sci. USA 111, 5694–5699 (2014).
pubmed: 24706808 pmcid: 3992628 doi: 10.1073/pnas.1322678111
Johnson, J. R. et al. Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64, a new disseminated multidrug-resistant commensal and extraintestinal pathogen. J. Clin. Microbiol. 57, e01664–e016618 (2019).
Potrykus, J. & Wegrzyn, G. Chloramphenicol-sensitive Escherichia coli strain expressing the chloramphenicol acetyltransferase (cat) gene. Antimicrob. Agents Chemother. 45, 3610–3612 (2001).
pubmed: 11709351 pmcid: 90880 doi: 10.1128/AAC.45.12.3610-3612.2001
Potrykus, J. & Wegrzyn, G. The acrAB locus is involved in modulating intracellular acetyl coenzyme A levels in a strain of Escherichia coli CM2555 expressing the chloramphenicol acetyltransferase (cat) gene. Arch. Microbiol. 180, 362–366 (2003).
pubmed: 14614545 doi: 10.1007/s00203-003-0592-x
Pulford, C. V. et al. Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa. Nat. Microbiol. 6, 327–338 (2021).
pubmed: 33349664 doi: 10.1038/s41564-020-00836-1
Civljak, R., Giannella, M., Di Bella, S. & Petrosillo, N. Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century. Expert Rev. Anti Infect. Ther. 12, 249–264 (2014).
pubmed: 24392752 doi: 10.1586/14787210.2014.878647
Sood, S. Chloramphenicol—a potent armament against multi-drug resistant (MDR) gram negative Bacilli? J. Clin. Diagn. Res. 10, DC01–DC03 (2016).
pubmed: 27042458 pmcid: 4800523
Rohana H., Hager-Cohen A., Azrad M., & Peretz A. Trend of changes in chloramphenicol resistance during the years 2017–2020: a retrospective report from Israel. Antibiotics 12, 196 (2023).
Glazko, A. J. et al. Biochemical studies on chloramphenicol; tissue distribution and excretion studies. J. Pharm. Exp. Ther. 96, 445–459 (1949).
Ambrose, P. J. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. Clin. Pharmacokinet. 9, 222–238 (1984).
pubmed: 6375931 doi: 10.2165/00003088-198409030-00004
Geurtsen, J. et al. Genomics and pathotypes of the many faces of Escherichia coli. FEMS Microbiol. Rev. 46, fuac031 (2022).
Harmer, C. J., Moran, R. A. & Hall, R. M. Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio 5, e01801–e01814 (2014).
pubmed: 25293759 pmcid: 4196232 doi: 10.1128/mBio.01801-14
Harmer, C. J. & Hall, R. M. IS26 cannot move alone. J. Antimicrob. Chemother. 76, 1428–1432 (2021).
pubmed: 33686401 doi: 10.1093/jac/dkab055
Martinez, J. L., Coque, T. M. & Baquero, F. What is a resistance gene? Ranking risk in resistomes. Nat. Rev. Microbiol. 13, 116–123 (2015).
pubmed: 25534811 doi: 10.1038/nrmicro3399
Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).
pubmed: 19363495 doi: 10.1038/nmeth.1318
Hunt, M. et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Micro. Genom. 3, e000131 (2017).
De Coster, W., D’Hert, S., Schultz, D. T., Cruts, M. & Van Broeckhoven, C. NanoPack: visualizing and processing long-read sequencing data. Bioinformatics 34, 2666–2669 (2018).
pubmed: 29547981 pmcid: 6061794 doi: 10.1093/bioinformatics/bty149
Kolmogorov, M., Yuan, J., Lin, Y. & Pevzner, P. A. Assembly of long, error-prone reads using repeat graphs. Nat. Biotechnol. 37, 540–546 (2019).
pubmed: 30936562 doi: 10.1038/s41587-019-0072-8
Shen, W., Le, S., Li, Y. & Hu, F. SeqKit: a cross-platform and ultrafast toolkit for FASTA/Q file manipulation. PLoS One 11, e0163962 (2016).
pubmed: 27706213 pmcid: 5051824 doi: 10.1371/journal.pone.0163962
Aziz, R. K. et al. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9, 75 (2008).
pubmed: 18261238 pmcid: 2265698 doi: 10.1186/1471-2164-9-75
Siguier, P., Perochon, J., Lestrade, L., Mahillon, J. & Chandler, M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 34, D32–D36 (2006).
pubmed: 16381877 doi: 10.1093/nar/gkj014
Johansson, M. H. K. et al. Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder. J. Antimicrob. Chemother. 76, 101–109 (2021).
pubmed: 33009809 doi: 10.1093/jac/dkaa390
Neron, B. et al. IntegronFinder 2.0: identification and analysis of integrons across bacteria, with a focus on antibiotic resistance in Klebsiella. Microorganisms 10, 700 (2022).
Bortolaia, V. et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J. Antimicrob. Chemother. 75, 3491–3500 (2020).
pubmed: 32780112 pmcid: 7662176 doi: 10.1093/jac/dkaa345
Gilchrist, C. L. M. & Chooi, Y. H. Clinker & clustermap.js: automatic generation of gene cluster comparison figures. Bioinformatics 37, 2473–2475 (2021).
pubmed: 33459763 doi: 10.1093/bioinformatics/btab007
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal 17, 3 (2011).
Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput Biol. 19, 455–477 (2012).
pubmed: 22506599 pmcid: 3342519 doi: 10.1089/cmb.2012.0021
Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686(2019).
Griffith D. M., Veech J. A., & Marsh C. J. cooccur: probabilistic species co-occurrence analysis in R. J. Stat. Softw. 69, 1–17 (2016).
Feldgarden, M. et al. AMRFinderPlus and the reference gene catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci. Rep. 11, 12728 (2021).
pubmed: 34135355 pmcid: 8208984 doi: 10.1038/s41598-021-91456-0
Graf, F. E. et al. Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase producing Enterobacterales. GitHub https://doi.org/10.5281/zenodo.13861919 (2024).

Auteurs

Fabrice E Graf (FE)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK. fabrice.graf@lstmed.ac.uk.

Richard N Goodman (RN)

Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.

Sarah Gallichan (S)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Sally Forrest (S)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Esther Picton-Barlow (E)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Alice J Fraser (AJ)

Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.

Minh-Duy Phan (MD)

Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.

Madalitso Mphasa (M)

Malawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.

Alasdair T M Hubbard (ATM)

Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK.

Patrick Musicha (P)

Malawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.

Mark A Schembri (MA)

Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.

Adam P Roberts (AP)

Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.

Thomas Edwards (T)

Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.

Joseph M Lewis (JM)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Malawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Nicholas A Feasey (NA)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Malawi-Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
School of Medicine, University of St Andrews, St Andrews, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH